Insights

EP. 1: Defining OFF-Episodes in Parkinson’s Disease

EP. 2: Subcutaneous Apomorphine for Managing PD OFF-Episodes

EP. 1: An Overview of Etiology and Prevalence of Pediatric MS

EP. 2: Clinical Presentation of Pediatric Multiple Sclerosis

EP. 3: Differential Diagnosis of Pediatric Multiple Sclerosis

EP. 4: Diagnostic Testing for Pediatric Multiple Sclerosis

EP. 5: Emotional, Social, and Cognitive Challenges in Pediatric MS

EP. 6: Treatment Goals and Response Monitoring in Pediatric MS

EP. 1: An Overview of Excessive Daytime Sleepiness (EDS)

EP. 2: Signs and Symptoms of Narcolepsy

EP. 3: Pathophysiology and Risk Factors for Narcolepsy

EP. 4: Differential Diagnosis of Patients with Narcolepsy

EP. 5: Behavioral Approaches to the Management of Narcolepsy

EP. 6: Pharmacological Approaches to the Management of Narcolepsy

EP. 7: Recent Approvals of Pitolisant and Solriamfetol for EDS

EP. 8: The Impact of COVID-19 on the Management of Narcolepsy

EP. 9: Future Improvements in the Management of Narcolepsy

EP. 1: Acute Migraine Management: Overview and Unmet Needs

EP. 2: Goals of and Recommended Approach for Acute Treatment

EP. 3: Acute Migraine Treatment: Pain Freedom and Guidelines

EP. 4: Therapy Assessment: Pain Relief & Onset Monitorization

EP. 5: The Importance of Patient Communication

EP. 6: Recent Approvals for Acute Migraine

EP. 7: The Significance of 5-HT1F Agonist Approval

EP. 8: 5-HT1F Agonist Toxicity Profile and Role in Paradigm

EP. 9: CGRP Receptor Agonists: Safety and Efficacy

EP. 10: The Role of Developing Agents in Acute Migraine Paradigm

EP. 1: Overview of Dravet Syndrome

EP. 2: Importance of Early Diagnosis of Dravet Syndrome

EP. 3: Treatment Options for Dravet Syndrome

EP. 4: Approval of Cannabidiol and Fenfluramine for Dravet

EP. 5: Choosing Cannabidiol or Fenfluramine for Dravet

EP. 6: Future Outlook for Dravet Syndrome

EP. 1: A 55-Year-Old Woman With Epilepsy

EP. 2: Epilepsy Prevalence and Therapy Resistance

EP. 3: Seizure Classification and Goals of Therapy

EP. 4: Antiepileptic Therapy Half-Life, Dosing & Black Box Warning

EP. 5: Antiepileptic Therapy Adverse Effects and Nonadherence

EP. 6: How Treatment Efficacy Is Determined

EP. 7: A Treatment Option for Uncontrolled Partial-Onset Seizures

EP. 8: Real-World Practice: Perampanel for Partial-Onset Seizures

EP. 9: Epilepsy Case Presentation and Diagnostic Process

EP. 10: The Classification of Epilepsy and Seizures

EP. 11: Anticonvulsants to Treat Epilepsy and Alternatives

EP. 12: How Epilepsy Treatment Efficacy Is Determined

EP. 13: Addressing Nonadherence to Therapy

EP. 14: Treating Patients Who Are Unresponsive to Therapy